Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Smolen, Josef S, Prof, Beaulieu, Andre, MD, Rubbert-Roth, Andrea, MD, Ramos-Remus, Cesar, Prof, Rovensky, Josef, Prof, Alecock, Emma, MSc, Woodworth, Thasia, MD, Alten, Rieke, MD
Published in The Lancet (British edition) (22.03.2008)
Published in The Lancet (British edition) (22.03.2008)
Get full text
Journal Article
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
Bijlsma, Johannes W J, Prof, Welsing, Paco M J, PhD, Woodworth, Thasia G, MD, Middelink, Leonie M, MSc, Pethö-Schramm, Attila, MD, Bernasconi, Corrado, MD, Borm, Michelle E A, PhD, Wortel, Cornelis H, MD, ter Borg, Evert Jan, MD, Jahangier, Z Nazira, MD, van der Laan, Willemijn H, MD, Bruyn, George A W, MD, Baudoin, Paul, MD, Wijngaarden, Siska, MD, Vos, Petra A J M, MD, Bos, Reinhard, MD, Starmans, Mirian J F, MD, Griep, Eduard N, MD, Griep-Wentink, Joanna R M, MD, Allaart, Cornelia F, MD, Heurkens, Anton H M, MD, Teitsma, Xavier M, MSc, Tekstra, Janneke, MD, Marijnissen, Anne Carien A, PhD, Lafeber, Floris P J, Prof, Jacobs, Johannes W G, Dr
Published in The Lancet (British edition) (23.07.2016)
Published in The Lancet (British edition) (23.07.2016)
Get full text
Journal Article